1. Home
  2. IMCC vs FRES Comparison

IMCC vs FRES Comparison

Compare IMCC & FRES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCC
  • FRES
  • Stock Information
  • Founded
  • IMCC 1980
  • FRES 2010
  • Country
  • IMCC Israel
  • FRES United States
  • Employees
  • IMCC N/A
  • FRES N/A
  • Industry
  • IMCC Medicinal Chemicals and Botanical Products
  • FRES Medical Specialities
  • Sector
  • IMCC Health Care
  • FRES Health Care
  • Exchange
  • IMCC Nasdaq
  • FRES Nasdaq
  • Market Cap
  • IMCC 8.0M
  • FRES 6.4M
  • IPO Year
  • IMCC N/A
  • FRES 2020
  • Fundamental
  • Price
  • IMCC $2.57
  • FRES $2.40
  • Analyst Decision
  • IMCC
  • FRES
  • Analyst Count
  • IMCC 0
  • FRES 0
  • Target Price
  • IMCC N/A
  • FRES N/A
  • AVG Volume (30 Days)
  • IMCC 30.1K
  • FRES 12.8K
  • Earning Date
  • IMCC 08-12-2024
  • FRES 09-17-2024
  • Dividend Yield
  • IMCC N/A
  • FRES N/A
  • EPS Growth
  • IMCC N/A
  • FRES N/A
  • EPS
  • IMCC N/A
  • FRES N/A
  • Revenue
  • IMCC $53,787,543.00
  • FRES $2,345,304.00
  • Revenue This Year
  • IMCC $11.51
  • FRES N/A
  • Revenue Next Year
  • IMCC $19.17
  • FRES N/A
  • P/E Ratio
  • IMCC N/A
  • FRES N/A
  • Revenue Growth
  • IMCC 12.87
  • FRES N/A
  • 52 Week Low
  • IMCC $1.13
  • FRES $1.83
  • 52 Week High
  • IMCC $8.10
  • FRES $40.50
  • Technical
  • Relative Strength Index (RSI)
  • IMCC 48.84
  • FRES 35.66
  • Support Level
  • IMCC $2.16
  • FRES $1.83
  • Resistance Level
  • IMCC $2.98
  • FRES $2.68
  • Average True Range (ATR)
  • IMCC 0.34
  • FRES 0.38
  • MACD
  • IMCC 0.04
  • FRES -0.04
  • Stochastic Oscillator
  • IMCC 65.61
  • FRES 30.41

About IMCC IM Cannabis Corp.

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

About FRES Fresh2 Group Limited

Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.

Share on Social Networks: